Introduction
The endothelial cell (EC) is the major cell type in the vascular intima, playing an important role in maintaining vessel biology and hemostasis [6] . Its dysfunction can lead to the development of vascular diseases, such as atherosclerosis [19] . Endothelial behavior is closely related to angiogenesis, such as proliferation, migration, and basement membrane degeneration [26] . Blood vessels generated from the differentiation of EC progenitors are associated with a process called vasculogenesis [17] . Once vessels form, ECs experience tissue-specific modifications, making vessels functionally different from each other [4] .
The maturation process of the endothelium is affected by signals from other neighboring cell types. In fact, the formation of a vascular structure involves an interaction between ECs and surrounding cells, including smooth muscle cells (SMCs) and pericytes. Under physiological conditions, the association between these cells results in vascular maturation and stabilization [1, 16] . The interaction between cells depends on various growth factors that show different profiles in physiological and pathological conditions. MicroRNAs (miRNAs, miRs) are 22~26-nucleotide-long noncoding RNAs, derived from a relatively long precursor through Dicer catalysis, which guide inhibitory complexes to specific mRNAs [3] . MicroRNAs have been proven to participate in various physiological and pathological processes, such as those of vessels [8, 12] . Previous studies have provided solid evidence that miR-143/145 can be transmitted from ECs to SMCs and regulate the phenotype and function of the SMCs [14] . For example, miR-143/145 were found to have collaboratively targeted a network of Communication between endothelial cells (ECs) and smooth muscle cells (SMCs) via miR-143/145 clusters is vital to vascular stability. Previous research demonstrates that miR-143/145 released from ECs can regulate SMC proliferation and migration. In addition, a recent study has found that SMCs also have the capability of manipulating EC function via miR-143/145. In the present study, we artificially increased the expression of miR-143/145 in ECs, to mimic a similar change caused by miR-143/145 released by SMCs, and applied untargeted metabolomics analysis, aimed at investigating the consequential effect of miR-143/145 overexpression. Our results showed that miR-143/145 overexpression alters the levels of metabolites involved in energy production, DNA methylation, and oxidative stress. These changed metabolites indicate that metabolic pathways, such as the SAM cycle and TCA cycle, exhibit significant differences from the norm with miR-143/145 overexpression. transcription factors, including Elk-1 (ELK1, a member of the ETS oncogene family), myocardin, and Kruppel-like factor 4, to promote the stabilization of SMCs [9] . Interestingly, a recent study demonstrates that miR-143/145 released by SMCs can affect the proliferation as well as differentiation of ECs, and then modulate vessel stabilization [7] . However, the mechanism behind the effect of miR-143/145 on ECs remains unclear.
Metabolism is involved in nearly all aspects of cellular functioning, directly or indirectly. Metabolome profiling, a method to screen small molecule production of biochemical processes, has been used to acquire information about various metabolic pathways [23] . Here, we investigated the metabolome of ECs via the overexpression of miR-143/145, thereby demonstrating the metabolic changes that occur in cellular communication and attempting to shed light on the hitherto unclear link between microRNAs and metabolic pathways.
Materials and Methods

Materials
All standards for identification of metabolites and normalization were procured from Sigma-Aldrich (St. MO, USA). Acetonitrile, ultrapure water, formic acid, ammonium fluoride and EDTA were also acquired from Sigma-Aldrich. Dulbecco modified Eagle's medium (DMEM), dialyzed fetal bovine serum (FBS), and penicillinstreptomycin (PS) were sourced from Gibco (Life Technologies, NY, USA).
Lentiviral Transfection of Endothelial Cells
Endothelial cells were plated and cultured in a 6-well plate with DMEM containing 10% FBS and 1% PS until 30-40% confluence. After that, the cells were infected overnight with 2 ml/well lentiviral supernatant containing the EGFP gene and miR-143/145 precursor or negative control in the presence of 8 µg/ml polybrene. The next day, the viral supernatant was replaced with fresh growth medium and incubated at 37°C and 5% CO 2 . At 72 h after incubation, the cells were observed at an excitation wavelength of 488 nm and the percentage of successfully infected cells was estimated.
PCR Assay
To evaluate the relative concentration of miR-143/45, Trizol reagent (Invitrogen) was used to extract the total RNA. To quantitate miR-143 and miR-145 concentrations, an NCode miRNA First Strand cDNA synthesis kit (Invitrogen) was applied to polyadenylate and the total RNA was reversely transcribed. Quantitative real-time PCR (qPCR) was performed with SYBR Green PCR master mix (Applied Biosystems) on an ABI 7300 system. The primers were CCCTCTAACACCCCTTCTCC (miR-143 forward), TCTCAGACTCCCAACTGACCA (miR-143 reverse), CCAGAGGGTTTCCGGTACTT (miR-145 forward), and CGGATG TGGCTTATTGCTCT (miR-145 reverse). Every sample was normalized according to the internal control, U6 snRNA. Fold changes were calculated using the method of relative quantification (2 -∆∆Ct ).
Metabolite Extraction
On the day of harvest, the medium was carefully aspirated from the wells with transfected ECs (miR-143/145 mimic or blank plasmid) and the cells were washed. Then 1 ml of precooled (4°C) ultrapure water with 1 mM HEPES and 1 mM EDTA was added into the wells. After that, the cells were scratched from the plates, sonicated for 1 min, and treated with three freeze-thaw cycles using liquid nitrogen. Next, the samples were cooled for 1 h at −20°C, followed by 20 min centrifugation at 13,000 rpm (4°C). HPLC vials were utilized to collect the supernatant.
LC-MS/ MS Analysis
Analysis was mainly performed by the method of Benton et al. [5] . In brief, an Agilent 1290 liquid chromatography system (Agilent Technologies, Santa Clara, CA, USA) and an AB 5600 TripleTOF were used to quantity and identify the metabolites. A 2.1 mm × 50 mm Agilent Eclipse Plus-C18 1.8 µm particle column with a 2.1 mm × 30 mm Agilent Zorbax SB-C18 3.5 µm particle guard column was equipped to separate the different metabolites. The separation was achieved under a column temperature of 40°C using a controlled gradient of mobile phase A, which consisted of 0.1% (v/v) formic acid in water, and mobile phase B, composed of 0.1% formic acid in acetonitrile, at a flow rate of 0.4 ml/min. The gradient flow was first set at 5% (v/v) B for 2 min, linearly increased to 95% B over 11 min, and maintained at this composition for an additional 2 min. The flow rate was set at 50 µl/min and the injection volume of the sample was 5 µl.
ESI source configurations for TripleTOF were set as follows: ion source gas 1 (GS1) as 35, ion source gas 2 (GS2) as 35, curtain gas (CUR) as 30, source temperature as 550°C, and ionspray voltage floating as −4,500 V in negative mode. The instrument was set to acquire over the m/z range 50-1,000 Da for TOF MS scans and the m/z range 25-1,000 Da for the production of ion scans in auto MS/MS acquisition. The accumulation time for TOF MS scans and the production ion scans were set at 0.25 sec/spectra and 0.05 sec/spectra, respectively, and the cycle time was 1 sec. The production ion scan was based on information-dependent acquisition, and was triggered when the full-scan experiment detected small molecules with m/z values between 50 and 1,000 Da. The collision energy of the production ion scan was set at −30 V with ±15 V spread, and the declustering potential was set at −100 V.
Data Processing and Statistical Analysis
For PCR data, the data were shown as the mean values ± SEM and a t-test was used to evaluate the statistical significance using
